Multicenter Open-Label Tacrolimus Inhalation Powder Trial Evaluating Safety, Tolerability, Efficacy and Pharmacokinetics (pk) in Lung Transplant (ltx) Recipients with Significant Renal Impairment

被引：0
|
作者：
Snell, G. [1 ]
Levvey, B. [1 ]
Westall, G. [1 ]
Christensen, D. [2 ]
Hudson, C. [2 ]
Mikhak, Z. [2 ]
机构：
[1] Alfred Hosp, Melbourne, Vic, Australia
[2] TFF Pharmaceut, Ft Worth, TX USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2024年 / 43卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
638
引用
收藏
页码：S309 / S309
页数：1
相关论文
共 50 条
  • [21] Trial in progress: A phase 1, multicenter, open-label, dose-exploration and dose-expansion study evaluating the safety, tolerability, pharmacokinetics, and efficacy of AMG650 in subjects with advanced solid tumors.
    Govindan, Ramaswamy
    Townsend, Amanda Rose
    Miller, Kathy D.
    Mehmi, Inderjit
    Kuboki, Yasutoshi
    Dumbrava, Ecaterina Elena
    Hamilton, Erika P.
    Vuu, Irene
    Rasmussen, Erik
    Mileshkin, Linda R.
    Genta, Sofia
    Iwata, Hiroji
    Adams, Sylvia
    Fujii, Hisaki
    Chawla, Sant P.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [22] An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients with moderate renal insufficiency
    Peddi, VR
    Jensik, S
    Pescovitz, M
    Pirsch, J
    Adler, SH
    Thistlethwaite, JR
    Vincenti, F
    Cohen, DJ
    CLINICAL TRANSPLANTATION, 2005, 19 (01) : 130 - 136
  • [23] Interchangeability of ciclosporin formulations in stable adult renal transplant recipients: comparison of Equoral and Neoral capsules in an international, multicenter, randomized, open-label trial
    Vitko, Stefan
    Ferkl, Marek
    KIDNEY INTERNATIONAL, 2010, 77 : S12 - S16
  • [24] A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment
    Saif, Muhammad Wasif
    Becerra, Carlos R.
    Fakih, Marwan G.
    Sun, Weijing
    Popovic, Lazar
    Krishnamurthi, Smitha
    George, Thomas J.
    Rudek, Michelle A.
    Shepard, Dale R.
    Skopek, Jiri
    Sramek, Vladimir
    Zaric, Bojan
    Yamamiya, Ikuo
    Benhadji, Karim A.
    Hamada, Kensuke
    He, Yaohua
    Rosen, Lee
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (03) : 485 - 497
  • [25] A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment
    Muhammad Wasif Saif
    Carlos R. Becerra
    Marwan G. Fakih
    Weijing Sun
    Lazar Popovic
    Smitha Krishnamurthi
    Thomas J. George
    Michelle A. Rudek
    Dale R. Shepard
    Jiri Skopek
    Vladimir Sramek
    Bojan Zaric
    Ikuo Yamamiya
    Karim A. Benhadji
    Kensuke Hamada
    Yaohua He
    Lee Rosen
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 485 - 497
  • [26] A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma
    Sofen, Howard
    Gross, Kenneth G.
    Goldberg, Leonard H.
    Sharata, Harry
    Hamilton, Tiffani K.
    Egbert, Barbara
    Lyons, Benjamin
    Hou, Jeannie
    Caro, Ivor
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (01) : 99 - U180
  • [27] Efficacy and safety of enteric-coated mycophenolate sodium (myfortic) in de novo renal transplant recipients: Results of a 12-month multicenter, open-label, prospective study
    Vogt, B.
    Antoniadis, A.
    Klinger, M.
    Vitko, S.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (05) : 1301 - 1306
  • [28] Safety and efficacy of immunoguided prophylaxis for cytomegalovirus disease in low-risk lung transplant recipients in Spain: a multicentre, open-label, randomised, phase 3 noninferiority trial
    Paez-Vega, Aurora
    Vaquero-Barrios, Jose M.
    Ruiz-Arabi, Elisa
    Iturbe-Fernandez, David
    Alonso, Rodrigo
    Ussetti-Gil, Piedad
    Monforte, Victor
    Pastor, Amparo
    Fernandez-Moreno, Raquel
    Mora, Victor M.
    Erro-Iribarren, Marta
    Quezada, Carlos A.
    Berastegui, Cristina
    Cifrian-Martinez, Jose M.
    Cano, Angela
    Caston, Juan J.
    Machuca, Isabel
    Lobo-Acosta, Maria A.
    Gutierrez-Gutierrez, Belen
    Cantisan, Sara
    Torre-Cisneros, Julian
    LANCET REGIONAL HEALTH-EUROPE, 2025, 52
  • [29] Pharmacokinetics, safety, and tolerability of siponimod (BAF312) in subjects with severe renal impairment: A single-dose, open-label, parallel-group study
    Gardin, Anne
    Dodman, Angela
    Kalluri, Sampath
    Neelakantham, Srikanth
    Tan, Xuemei
    Legangneux, Eric
    Shakeri-Nejad, Kasra
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (01) : 54 - 65
  • [30] Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study
    Kamar, Nassim
    Cassuto, Elisabeth
    Piotti, Giovanni
    Govoni, Mirco
    Ciurlia, Giorgia
    Geraci, Silvia
    Poli, Gianluigi
    Nicolini, Gabriele
    Mariat, Christophe
    Essig, Marie
    Malvezzi, Paolo
    Le Meur, Yannick
    Garrigue, Valerie
    Del Bello, Arnaud
    Rostaing, Lionel
    ADVANCES IN THERAPY, 2019, 36 (02) : 462 - 477
12345